Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Denis Jullien is active.

Publication


Featured researches published by Denis Jullien.


Journal of Immunology | 2000

Overexpression of CD1d by Keratinocytes in Psoriasis and CD1d-Dependent IFN-γ Production by NK-T Cells

Brian Bonish; Denis Jullien; Yves Dutronc; Barbara Bei Huang; Robert Modlin; Franca M. Spada; Steven A. Porcelli; Brian J. Nickoloff

The MHC class I-like protein CD1d is a nonpolymorphic molecule that plays a central role in development and activation of a subset of T cells that coexpress receptors used by NK cells (NK-T cells). Recently, T cells bearing NK receptors were identified in acute and chronic lesions of psoriasis. To determine whether NK-T cells could interact with epidermal cells, we examined the pattern of expression of CD1d in normal skin, psoriasis, and related skin disorders, using a panel of CD1d-specific mAbs. CD1d was expressed by keratinocytes in normal skin, although expression was at a relatively low level and was generally confined to upper level keratinocytes immediately beneath the lipid-rich stratum corneum. In contrast, there was overexpression of CD1d in chronic, active psoriatic plaques. CD1d could be rapidly induced on keratinocytes in normal skin by physical trauma that disrupted barrier function or by application of a potent contact-sensitizing agent. Keratinocytes displayed enhanced CD1d following exposure to IFN-γ. Combining CD1d-positive keratinocytes with human NK-T cell clones resulted in clustering of NK-T cells, and while no significant proliferation ensued, NK-T cells became activated to produce large amounts of IFN-γ. We conclude that CD1d can be expressed in a functionally active form by keratinocytes and is up-regulated in psoriasis and other inflammatory dermatoses. The ability of IFN-γ to enhance keratinocyte CD1d expression and the subsequent ability of CD1d-positive keratinocytes to activate NK-T cells to produce IFN-γ, could provide a mechanism that contributes to the pathogenesis of psoriasis and other skin disorders.


Journal of Clinical Investigation | 1997

Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy.

Daniel H. Libraty; Lisa E. Airan; Koichi Uyemura; Denis Jullien; Brad Spellberg; Thomas H. Rea; Robert L. Modlin

The ability of monocytes to influence the nature of the T cell response to microbial pathogens is mediated in part by the release of cytokines. Of particular importance is the release of IL-12 and IL-10 by cells of the monocyte/macrophage lineage upon encountering the infectious agent. IL-12 promotes cell mediated immunity (CMI) to intracellular pathogens by augmenting T-helper type 1 responses, whereas IL-10 downregulates these responses. The ability of IFN-gamma to modulate the balance between IL-12 and IL-10 production was examined by studying leprosy as a model. In response to Mycobacterium leprae stimulation, IFN-gamma differentially regulated IL-12 and IL-10 production resulting in upregulation of IL-12 release and downregulation of IL-10 release. Furthermore, we determined that the mechanism by which IFN-gamma downregulates IL-10 was through the induction of IL-12. The data suggest a model of lymphocyte-monocyte interaction whereby the relative presence or absence of IFN-gamma in the local microenvironment is a key determinant of the type of monocyte cytokine response, and hence the degree of CMI in the host response to infection.


Journal of Immunology | 2000

Evidence for Human CD4+ T Cells in the CD1-Restricted Repertoire: Derivation of Mycobacteria-Reactive T Cells from Leprosy Lesions

Peter A. Sieling; Maria-Teresa Ochoa; Denis Jullien; David S. Leslie; Shereen Sabet; Jean-Pierre Rosat; Anne E. Burdick; Thomas H. Rea; Michael B. Brenner; Steven A. Porcelli; Robert L. Modlin

Both the CD4−CD8− (double negative) and CD4−CD8+ T cell lineages have been shown to contain T cells which recognize microbial lipid and glycolipid Ags in the context of human CD1 molecules. To determine whether T cells expressing the CD4 coreceptor could recognize Ag in the context of CD1, we derived CD4+ T cell lines from the lesions of leprosy patients. We identified three CD4+ Mycobacterium leprae-reactive, CD1-restricted T cell lines: two CD1b restricted and one CD1c restricted. These T cell lines recognize mycobacterial Ags, one of which has not been previously described for CD1-restricted T cells. The response of CD4+ CD1-restricted T cells, unlike MHC class II-restricted T cells, was not inhibited by anti-CD4 mAb, suggesting that the CD4 coreceptor does not impact positive or negative selection of CD1-restricted T cells. The CD4+ CD1-restricted T cell lines produced IFN-γ and GM-CSF, the Th1 pattern of cytokines required for cell-mediated immunity against intracellular pathogens, but no detectable IL-4. The existence of CD4+ CD1-restricted T cells that produce a Th1 cytokine pattern suggests a contributory role in immunity to mycobacterial infection.


Journal of Immunology | 1999

CD1 Expression by Dendritic Cells in Human Leprosy Lesions: Correlation with Effective Host Immunity

Peter A. Sieling; Denis Jullien; Monica Dahlem; Thomas F. Tedder; Thomas H. Rea; Robert L. Modlin; Steven A. Porcelli


Journal of Immunology | 1997

IL-15, an immunomodulator of T cell responses in intracellular infection.

Denis Jullien; Peter A. Sieling; Koichi Uyemura; N D Mar; Thomas H. Rea; R L Modlin


Journal of Immunology | 1998

IL-15 Enhances the Response of Human γδ T Cells to Nonpetide Microbial Antigens

Verónica E. García; Denis Jullien; Mark Song; Koichi Uyemura; Ke Shuai; Craig T. Morita; Robert L. Modlin


Journal of Immunology | 1998

IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens.

Verónica E. García; Denis Jullien; Song M; Koichi Uyemura; Ke Shuai; Craig T. Morita; R L Modlin


Journal of Immunology | 1998

B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy.

Katia Schlienger; Koichi Uyemura; Denis Jullien; Peter A. Sieling; Thomas H. Rea; Peter S. Linsley; Robert L. Modlin


Revue Francaise D Allergologie | 2017

Nécrolyse épidermique toxique : physiopathologie et avancées thérapeutiques

Axel-Patrice Villani; Marc Vocanson; Léo Laoubi; Denis Jullien; F. Bérard; Jean-François Nicolas; Benoit Bensaid


Journal of Dermatological Science | 1998

CD1d1 is expressed in mouse epidermis on keratinocytes and Langerhans cells

Denis Jullien; Hitoshi Akiba; J. Kerhen; Françoise Horand; Marie-Thérèse Ducluzeau; M. Krasteva; Dominique Kaiserlian; Alain Claudy; A. Bendelac; J.-F. Nicolas

Collaboration


Dive into the Denis Jullien's collaboration.

Top Co-Authors

Avatar

Koichi Uyemura

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas H. Rea

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Steven A. Porcelli

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Craig T. Morita

Roy J. and Lucille A. Carver College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Ke Shuai

University of California

View shared research outputs
Top Co-Authors

Avatar

R L Modlin

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge